Cancer BiologybioRxivPreprint
The V617F mutation in JAK2 renders myeloid cells more sensitive to IL-6-mediated gp130 signaling
Henning Schurse, Marcelo A. S. Toledo, Andrea Küster…·Gerhard Müller‐Newen
This study shows that the JAK2 V617F mutation enhances IL-6 sensitivity by promoting gp130 dimerization and expression in myeloid cells, contributing to chronic inflammation in MPN.
DOI 10.1101/2025.10.10.681590